Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

3.46USD
21 Nov 2018
Change (% chg)

$0.07 (+2.06%)
Prev Close
$3.39
Open
$3.38
Day's High
$3.48
Day's Low
$3.32
Volume
379,940
Avg. Vol
495,544
52-wk High
$5.05
52-wk Low
$1.65

Select another date:

Fri, Nov 2 2018

Photo

FDA approves AcelRx Pharma's opioid pain drug

The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.

UPDATE 2-U.S. FDA approves AcelRx Pharma's opioid pain drug

Nov 2 The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.

AcelRx Pharma's opioid pain drug gets U.S. FDA nod

Nov 2 The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based pain treatment, a fast-acting pill.

AcelRx shares surge after FDA staff says opioid safe

AcelRx Pharmaceuticals Inc's shares surged 30 percent on Wednesday after U.S. Food and Administration staff said the company's opioid treatment was safe and effective, bringing it one step closer to a marketing approval.

UPDATE 2-AcelRx shares surge after FDA staff says opioid safe

Oct 10 AcelRx Pharmaceuticals Inc's shares surged 30 percent on Wednesday after U.S. Food and Administration staff said the company's opioid treatment was safe and effective, bringing it one step closer to a marketing approval.

BRIEF-AcelRx Announces FDA Acceptance Of NDA For Dsuvia

* ACELRX PHARMACEUTICALS INC - DSUVIA PDUFA DATE SET FOR NOVEMBER 3, 2018

BRIEF-Three Arch's Shares Of AcelRx Stock Acquired In Transaction Led By Leerink Revelation Partners And Industry Ventures

* THREE ARCH'S SHARES OF ACELRX COMMON STOCK ACQUIRED IN A PRIVATE TRANSACTION LED BY LEERINK REVELATION PARTNERS AND INDUSTRY VENTURES

Select another date: